We recently reported prospective results from a cohort of patients scheduled for elective cardiac surgery with cardiopulmonary bypass (CPB) in which most baseline clinical parameters of patients and surgery outcomes failed to demonstrate relationships with post-CPB antithrombin (AT) activity. In this extension study, a larger sample size (250 patients) was analyzed following general linear models. Patients' sociodemographic and pre-CPB clinical data as well as pre/post-CPB AT activity and outcomes were collected. There was a significant decrease of post-CPB AT activity (95.6 W 13.7-64.6 W 12.1%; P < 0.001). Univariate and multivariate analyses revealed that a decrease of approximately 1% post-CPB AT activity may be expected per 3 years increase in patient's age. Univariate analysis showed that post-CBP AT activity was inversely related to the need for transfusions, acute renal failure and occurrence of any complication (re-intervention, low cardiac output, arrhythmia, lung dysfunction, stroke, acute renal failure, mesenteric ischemia and re-hospitalization; P < 0.05). Multivariate analysis adjusted for age and pre-CPB AT did not show statistical significance. Odds ratio (OR) less than 1 was observed in most outcomes (0.8 on average), which suggested a reduction of the probability for an increase of 10% in post-CBP AT. Our results confirm the role of low postsurgery AT activity influencing outcomes in patients undergoing CPB. Blood Coagul Fibrinolysis 24:454-457 ß 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins. Blood Coagulation and Fibrinolysis 2013, 24:454-457 
Introduction
Cardiac surgery with cardiopulmonary bypass (CPB) poses a threat to the delicate balance between procoagulant and anticoagulant proteins due to the high amounts of thrombin produced by the contact of blood with the artificial surfaces of the bypass circuit [1] . Antithrombin (AT), the strongest endogenous anticoagulant [2] , has been reported to decrease its activity by 40-60% during and after CPB in comparison to baseline values. This is mainly due to consumption and reduced hepatic synthesis [3] , which has been correlated with worse postoperative outcomes [4] .
In an attempt to describe the profile of a Spanish population, we prospectively studied 149 patients scheduled for elective cardiac surgery with CPB to elucidate possible relationships between AT activity and a patient's clinical profile or surgery characteristics [5] . In that study we found that 29.5% patients required an additional dose of heparin during CPB to achieve activated clotting time (ACT) target. Mean pre-CPB AT was 96.5 AE 13.9%, undergoing a significant decrease during CPB (59.7%) and upon leaving the operating room (65.6%). Most baseline clinical parameters of patients and outcomes of surgery failed to present relationships with AT activity values before, during and after CPB.
However, a small but significant inverse correlation was observed between AT at the end of CPB and the patient's age, as well as between baseline pre-CPB AT and total heparin administered. These results partially corresponded with previous studies [6, 7] , which led to the conclusion that patient's age could be a moderate indicator of decreasing AT activity and that low pre-CPB AT activity could be a predictive sign of reduced anticoagulant efficacy of heparin during CPB. However, the possibility that a larger sample size could reveal other associations encouraged us to continue recruiting patients, to confirm the extent of relationships between AT activity and outcomes in patients undergoing CPB.
Patients and methods

Study characteristics
In order to find out the determinant factors of post-CBP AT activity as well as the association of post-CBP AT activity with outcomes, we conducted an extension of a previous study [5] statistically focused in general linear models. The study was set up in accordance with the Declaration of Helsinki, the Good Clinical Practice and the local ethics committee from the La Ribera University Hospital. Written informed consent was obtained from all patients. As in the former report [5] , patients under 18 years of age scheduled for elective CPB were excluded, as well as repair of congenital disease, off-pump or any emergency cardiac surgery, and pre-CPB use of intra-aortic balloon pump. For each patient, sociodemographic pre-CPB variables, baseline clinical parameters, anticoagulant and antiplatelet therapy, Euroscore risk estimate, data of surgery, AT activity and laboratory values, and outcomes at discharge were collected.
Cardiopulmonary bypass procedures
Details of anesthesia and CPB equipment and technique were carried out as described previously [5] . Briefly, after anesthesia (etomidate, remifentanil, and midazolam and cisatricurium) CPB was established through a standard median sternotomy, aortic root cannulation, and single or bi-caval atrial cannulation for venous return. The circuit priming volume before beginning CPB was 600 ml. Antegrade/retrograde intermittent cold blood cardioplegia (4 : 1) was used. The pump flow was set at 2.4-2.6 l/m 2 per min and the target mean arterial pressure at 65-70 mmHg. Body temperature during CPB was maintained between 32 and 378C. All patients received tranexamic acid intraoperatively (15-30 mg/kg body weight intravenously before the induction of anesthesia, 1 mg/kg body weight per min during CPB, and finally, 15-30 mg/kg body weight after the protamine dose).
The ACT was determined immediately after the induction of anesthesia [3 min after the loading heparin dose (300 IU/kg body weight), 5 min after the initiation of CPB, and subsequently every 15 min]. An ACT of 460 s or greater was considered satisfactory. A specific perioperative transfusion algorithm was applied to maintain hematocrit above 25%, according to the clinical condition, hemodynamic status, need for inotropic support, and age of the patient [5] . After the operation, all patients were released to the ICU. The clinical course of patients and post surgery complications were followed until discharge.
Sampling and data collection
Blood samples were collected and immediately centrifuged to obtain the plasma fraction to be frozen for analysis [serum creatinine, hematocrit, minimum protrombin time (PT) and AT activity levels (pre and post-CPB)] [5] . With regard to CPB operation, the type of surgery and duration of CBP were collected. Outcomes considered for analysis were: need for transfusion, reintervention and cause (due to bleeding, infection, or other), low cardiac output syndrome, perioperative acute myocardial infarction (AMI), arrhythmia, lung dysfunction, stroke, mesenteric ischemia, acute renal impairment, re-hospitalization, mortality after day 28, length of stay in ICU (days), and length of hospitalization (days).
Statistical analysis
Values are expressed as percentage (%), mean AE SD, median AE interquartile range (IQR), or odds ratio (OR) AE 95% confidence interval (CI) as appropriate. The difference in AT activity from pre to post-CPB was analyzed by a paired Student's t-test. The association between pre or operative data and post-CBP AT was assessed by univariate analysis (Wilcoxon, Kruskal-Wallis or Spearman correlation tests as appropriate) and multivariate analysis (general linear models). This included as covariates those variables that appeared in the univariate analysis at the 5% significance level. The association of post-CPB AT to outcome variables was investigated by univariate analysis (univariate logistic regression or Spearman correlation as appropriate) and multivariate analysis (logistic regression or general linear models) including preoperative and operative variables that were significantly associated with post-CPB AT in the previous multivariate analysis. A value of P 0.05 or less was considered statistically significant.
Results
Patient and cardiopulmonary bypass profiles
We collected data from 250 patients, of which 165 (66%) were male. Mean age was 67 AE 11.6 years with average BMI of 29.1 AE 4.5. Pre-CPB analytics showed mean serum creatinine 1.2 AE 1.0 mg/dl, hematocrit 37.1 AE 4.8%, PT 13.6 AE 0.9 s, and median Euroscore 5.4 AE 4.9. Most surgeries were coronary revascularization (46.8%), valve replacement (34.4%), or both combined (14.4%). Median CPB duration was 75.5 AE 35.0 min. Outcome variables are shown in Table 1 . Median lengths of ICU and hospital stay were 3 AE 3 and 8 AE 7 days, respectively. There was a significant decrease in AT activity from pre-CPB to post-CPB (from 95.6 AE 13.7% down to 64.6 AE 12.1%; t ¼ 36.6; DF ¼ 249; P < 0.001), which represented a drop of 31% (95% CI 29-33%) in AT activity levels.
Determinants of post-cardiopulmonary bypass antithrombin activity
Univariate analysis detected three pre-CPB factors associated with post-CPB AT activity: age (r ¼ À0.33; P < 0.001), Euroscore (r ¼ À0.19; P < 0.05), and pre-CPB AT activity (r ¼ 0.47; P < 0.001). In the multivariate analysis, both age and pre-CPB AT activity remained significantly associated to AT activity post-CPB (r ¼ À0.31 and r ¼ 0.38; P < 0.001). As illustrated in the regression plane in Fig. 1 , highest post-CPB AT activity was favored by young age in combination with high pre-CPB AT activity (e.g. around 95% post-CPB AT may be expected in a 30-year-old patient with 140% pre-CPB AT), whereas at the opposite edge, one would expect post-CPB AT activity of around 40% in a 90-year-old patient with 50% pre-CPB AT activity.
Association of post-cardiopulmonary bypass antithrombin activity to outcomes Univariate analysis showed that post-CBP AT activity was inversely related to the need for transfusion, acute AT activity and heparin efficacy in CPB Muedra et al. 455 renal failure and the occurrence of any complication (see Table 1 ). Mortality at day 28 showed a close-to-significant association (P ¼ 0.051). OR point estimates were lower than 1 (0.8 in average) for all outcomes (except perioperative AMI) in the univariate analysis, which suggests a reduction in the odds of an outcome related to an increase of 10% in post-CPB AT activity. However, when age and pre-CPB AT activity were adjusted for the multivariate analysis, the statistical significance was lost, despite OR estimates being similar. These results are summarized in Table 1 . Similar to what happened in the univariate analysis, OR point estimates were lower than 1 (0.8 in average) or very close to 1 in most outcomes.
Discussion
The role of pre-CPB AT activity in patients undergoing cardiac surgery with CPB on postoperative outcomes is a subject of debate. In this study we aimed to shed some light on this subject. As could be somewhat expected, the profile of the patients included in this extension study was similar to that from the original study [5] and comparable to that of other studies [8, 9] . In our study the mean pre-CPB AT activity level (around 95%) was within the normally accepted range of 80-120%, and predictably after CPB AT activity dropped down to around 65%. Apart from pre-CPB AT activity, our univariate analysis detected Euroscore to be associated with post-CPB AT activity, a relationship somewhat expected since Euroscore is a recognized method of calculating predicted operative mortality for these patients [10] . However, multivariate analysis only confirmed post-CPB AT activity association with regard to patient's age, which was in accordance with previous findings [8] .
Unlike our previous study, in this extension study, some outcomes such as transfusions and acute renal failure were associated with post-CPB AT levels. In contrast with the findings of others we did not detect association of major adverse cardiac events [7] . Interestingly, when outcomes were considered as a group (the so-called 'any complication' variable), there was a significant inverse association with post-CPB AT levels. In multivariate analysis, the trend was similar to that observed in univariate analysis, although not reaching statistical significance.
To summarize, the results from this extension study allowed going a step further than those of the former study. It confirms a role of low AT activity influencing the incidence of outcomes in patients undergoing CPB, although its precise effects could not be clearly established. An inverse association of post-CPB AT activity with age would support AT preventive treatment in elderly patients, who constitute a high risk group.
